Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
419.30
+8.55 (2.08%)
Sep 24, 2026, 11:10 AM IST
Gujarat Themis Biosyn Company Description
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals, medicinal chemicals, and active pharmaceutical ingredients in India and internationally.
The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O, an antibiotic for the treatment of traveller’s diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin.
The company was incorporated in 1981 and is based in Mumbai, India.
Gujarat Themis Biosyn Limited
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 221 |
| CEO | Sachin Patel |
Contact Details
Address: Themis House Mumbai, Gujarat 400104 India | |
| Phone | 91 22 6760 7080 |
| Website | gtbl.in |
Stock Details
| Ticker Symbol | GUJTHEM |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE942C01045 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sachin Dinesh Patel CChem., Ph.D. | MD and Director |
| Bhavik Shah | Senior Accounts Manager |
| Vineet Ganesh Gawankar | Company Secretary and Compliance Officer |
| Krupesh Patel | Chief Financial Officer |
| Do-Seon Kim | Chief Technical Officer |
| Falguni Desai | Assistant General Manager of Human Resources |
| Rajneesh Kedarnath Anand | Additional Non-Executive Non-Independent Director |